Susan Zolla‐Pazner

24.6k total citations · 2 hit papers
290 papers, 14.8k citations indexed

About

Susan Zolla‐Pazner is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Susan Zolla‐Pazner has authored 290 papers receiving a total of 14.8k indexed citations (citations by other indexed papers that have themselves been cited), including 232 papers in Virology, 155 papers in Immunology and 96 papers in Infectious Diseases. Recurrent topics in Susan Zolla‐Pazner's work include HIV Research and Treatment (231 papers), Immune Cell Function and Interaction (115 papers) and Monoclonal and Polyclonal Antibodies Research (92 papers). Susan Zolla‐Pazner is often cited by papers focused on HIV Research and Treatment (231 papers), Immune Cell Function and Interaction (115 papers) and Monoclonal and Polyclonal Antibodies Research (92 papers). Susan Zolla‐Pazner collaborates with scholars based in United States, France and United Kingdom. Susan Zolla‐Pazner's co-authors include Miroslaw K. Górny, Constance Williams, S Karwowska, Jiake Xu, Abraham Pinter, Phillipe N. Nyambi, Rosalyn E. Stahl, Timothy Cardozo, William Honnen and Aby Buchbinder and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Susan Zolla‐Pazner

287 papers receiving 14.3k citations

Hit Papers

Isolation of Human T-Cell Leukemia Virus in Acquired Immu... 1983 2026 1997 2011 1983 2004 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Isolation of Human T-Cell Leukemia Virus in Acquired Immune Deficiency Syndrome (AIDS)
    1983 791 citations Susan Zolla‐Pazner et al. profile →
  2. Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies
    2004 582 citations Susan Zolla‐Pazner et al. Journal of Virology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Zolla‐Pazner United States 68 11.2k 7.1k 5.2k 3.7k 3.3k 290 14.8k
Quentin J. Sattentau United Kingdom 65 10.1k 0.9× 6.9k 1.0× 4.5k 0.9× 2.2k 0.6× 3.7k 1.1× 171 14.7k
Michael S. Seaman United States 66 9.7k 0.9× 7.2k 1.0× 4.5k 0.9× 3.5k 1.0× 4.0k 1.2× 224 14.2k
Alexandra Trkola Switzerland 54 9.1k 0.8× 5.6k 0.8× 4.7k 0.9× 2.3k 0.6× 2.9k 0.9× 147 12.0k
Lynn Morris South Africa 62 8.5k 0.8× 4.2k 0.6× 7.3k 1.4× 1.5k 0.4× 2.4k 0.7× 275 13.8k
Galit Alter United States 68 5.1k 0.5× 9.6k 1.3× 5.3k 1.0× 2.4k 0.7× 3.1k 0.9× 310 16.6k
Paul R. Clapham United Kingdom 53 10.2k 0.9× 7.8k 1.1× 4.7k 0.9× 1.3k 0.3× 2.7k 0.8× 127 14.4k
John C. Kappes United States 54 8.8k 0.8× 4.7k 0.7× 4.9k 1.0× 1.0k 0.3× 4.0k 1.2× 163 13.8k
Per Johan Klasse United States 56 6.5k 0.6× 3.9k 0.6× 3.2k 0.6× 2.0k 0.6× 2.6k 0.8× 153 9.4k
Rogier W. Sanders Netherlands 60 8.3k 0.7× 4.6k 0.6× 4.0k 0.8× 3.2k 0.9× 4.6k 1.4× 212 11.9k
James Μ. Binley United States 46 7.6k 0.7× 4.3k 0.6× 3.2k 0.6× 2.4k 0.6× 2.2k 0.7× 80 8.8k

Countries citing papers authored by Susan Zolla‐Pazner

Since Specialization
Citations

This map shows the geographic impact of Susan Zolla‐Pazner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Zolla‐Pazner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Zolla‐Pazner more than expected).

Fields of papers citing papers by Susan Zolla‐Pazner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Zolla‐Pazner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Zolla‐Pazner. The network helps show where Susan Zolla‐Pazner may publish in the future.

Co-authorship network of co-authors of Susan Zolla‐Pazner

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Zolla‐Pazner. A scholar is included among the top collaborators of Susan Zolla‐Pazner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Zolla‐Pazner. Susan Zolla‐Pazner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fox, Alisa, Jessica Marino, Fatima Amanat, et al.. (2020). Robust and Specific Secretory IgA Against SARS-CoV-2 Detected in Human Milk. iScience. 23(11). 101735–101735. 150 indexed citations
2.
Zolla‐Pazner, Susan, Xiang‐Peng Kong, Xunqing Jiang, et al.. (2011). Cross-Clade HIV-1 Neutralizing Antibodies Induced with V3-Scaffold Protein Immunogens following Priming with gp120 DNA. Journal of Virology. 85(19). 9887–9898. 50 indexed citations
3.
Robinson, James E., Debra Elliott, David C. Montefiori, et al.. (2010). Quaternary Epitope Specificities of Anti-HIV-1 Neutralizing Antibodies Generated in Rhesus Macaques Infected by the Simian/Human Immunodeficiency Virus SHIV SF162P4. Journal of Virology. 84(7). 3443–3453. 37 indexed citations
4.
Dennison, S. Moses, Kara Anasti, Richard M. Scearce, et al.. (2010). Nonneutralizing HIV-1 gp41 Envelope Cluster II Human Monoclonal Antibodies Show Polyreactivity for Binding to Phospholipids and Protein Autoantigens. Journal of Virology. 85(3). 1340–1347. 27 indexed citations
5.
Kimura, Tetsuya, et al.. (2010). Structural Conservation Predominates Over Sequence Variability in the Crown of HIV Type 1's V3 Loop. AIDS Research and Human Retroviruses. 26(6). 717–723. 32 indexed citations
6.
Cardozo, Timothy, et al.. (2009). Worldwide Distribution of HIV Type 1 Epitopes Recognized by Human Anti-V3 Monoclonal Antibodies. AIDS Research and Human Retroviruses. 25(4). 441–450. 23 indexed citations
7.
Yuan, Wen, et al.. (2009). Oligomer-Specific Conformations of the Human Immunodeficiency Virus (HIV-1) gp41 Envelope Glycoprotein Ectodomain Recognized by Human Monoclonal Antibodies. AIDS Research and Human Retroviruses. 25(3). 319–328. 21 indexed citations
8.
Alam, S. Munir, Richard M. Scearce, Robert Parks, et al.. (2007). Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection. Journal of Virology. 82(1). 115–125. 85 indexed citations
9.
Cardozo, Timothy, Tetsuya Kimura, Sean Philpott, et al.. (2007). Structural Basis for Coreceptor Selectivity by The HIV Type 1 V3 Loop. AIDS Research and Human Retroviruses. 23(3). 415–426. 137 indexed citations
10.
Felsövályi, Klára, Arthur Nádas, Susan Zolla‐Pazner, & Timothy Cardozo. (2006). Distinct Sequence Patterns Characterize the V3 Region of HIV Type 1 gp120 from Subtypes A and C. AIDS Research and Human Retroviruses. 22(7). 703–708. 7 indexed citations
11.
Nádas, Arthur, Ping Zhong, Sherri Burda, et al.. (2004). Defining Human Immunodeficiency Virus (HIV) Type 1 Immunotypes with Six Human Monoclonal Antibodies. AIDS Research and Human Retroviruses. 20(1). 55–65. 4 indexed citations
12.
Zhong, Ping, Sherri Burda, Frank Konings, et al.. (2003). Genetic and Biological Properties of HIV Type 1 Isolates Prevalent in Villagers of the Cameroon Equatorial Rain Forests and Grass Fields: Further Evidence of Broad HIV Type 1 Genetic Diversity. AIDS Research and Human Retroviruses. 19(12). 1167–1178. 39 indexed citations
13.
Belisle, John T., et al.. (1998). Delineation of Human Antibody Responses to Culture Filtrate Antigens ofMycobacterium tuberculosis. The Journal of Infectious Diseases. 178(5). 1534–1538. 47 indexed citations
14.
Sattentau, Quentin J., Susan Zolla‐Pazner, & Pascal Poignard. (1995). Epitope exposure on functional, oligomeric HIV-1 gp41 molecules. Virology. 206(1). 713–717. 168 indexed citations
15.
Eddleston, Michael, Juan Carlos de la Torre, Jiake Xu, et al.. (1993). Molecular Mimicry Accompanying HIV-1 Infection: Human Monoclonal Antibodies That Bind to gp41 and to Astrocytes. AIDS Research and Human Retroviruses. 9(10). 939–944. 19 indexed citations
16.
Laal, Suman, Sherri Burda, Sandra Sharpe, & Susan Zolla‐Pazner. (1993). A Rapid, Automated Microtiter Assay for Measuring Neutralization of HIV-1. AIDS Research and Human Retroviruses. 9(8). 781–785. 14 indexed citations
17.
Zolla‐Pazner, Susan, Bonnie J. Mathieson, Mary Clare Walker, & Bruce D. Walker. (1992). Summary: Clinical Immunology Working Group. AIDS Research and Human Retroviruses. 8(8). 1441–1443. 1 indexed citations
18.
Karwowska, S, Miroslaw K. Górny, Aby Buchbinder, et al.. (1992). Production of Human Monoclonal Antibodies Specific for Conformational and Linear Non-V3 Epitopes of gp120. AIDS Research and Human Retroviruses. 8(6). 1099–1106. 76 indexed citations
19.
Zolla‐Pazner, Susan, et al.. (1992). Synergy Between Human Monoclonal Antibodies to HIV Extends Their Effective Biologic Activity Against Homologous and Divergent Strains. AIDS Research and Human Retroviruses. 8(8). 1395–1395. 6 indexed citations
20.
Zolla‐Pazner, Susan, et al.. (1991). Proliferative Response of Mononuclear Cells from HIV-Infected Patients to B-Cell Mitogens: Effects Of Lymphocyte Subset Frequency, T-Cell Defects and Prostaglandins. AIDS Research and Human Retroviruses. 7(11). 953–961. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Quentin J. Sattentau Breakdown of academic impact, for papers by Michael S. Seaman Breakdown of academic impact, for papers by Alexandra Trkola Breakdown of academic impact, for papers by Lynn Morris Breakdown of academic impact, for papers by Galit Alter Breakdown of academic impact, for papers by Paul R. Clapham Breakdown of academic impact, for papers by John C. Kappes Breakdown of academic impact, for papers by Per Johan Klasse Breakdown of academic impact, for papers by Rogier W. Sanders Breakdown of academic impact, for papers by James Μ. Binley
Rankless by CCL
2026